The Online Investor
Stock Buybacks
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
NTUS Buyback image

Natus Medical Incorporated Buyback

OLI recorded this information on 12/17/2019

Company: Natus Medical Incorporated
Buyback: NTUS buyback
$Amount Authorized: $50,000,000
Buyback Details: Natus Medical Incorporated (NASDAQ: NTUS) (the "Company" or "Natus"), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that its Board of Directors has approved a stock repurchase program, authorizing the repurchase of up to $50 million of the Company's common stock.

Natus Medical provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Co. provides product solutions for three end markets: Neuro, Newborn Care and Hearing & Balance. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for newborn jaundice, software systems for managing and tracking disorders and diseases for public health laboratories, computer-based audiological, otoneurologic and vestibular instrumentation for hearing and balance care personnel.
Open the NTUS Page at The Online Investor »

Company Name:  Natus Medical Inc.
Stock buyback:  NTUS buyback
Website:  www.natus.com
Sector:  Medical Instruments & Supplies
 

Open the NTUS Page at The Online Investor (in a new window) »

April 26, 2024    5:14 PM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree NTUS Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
NTUS Stock Forecast

Based on Zacks ABR data;
powered by Xignite

NTUS Buyback | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.